Silexion Therapeutics (SLXN) Other Working Capital Changes (2023 - 2026)
Silexion Therapeutics (SLXN) posted quarterly Other Working Capital Changes of -$4000.0 for Q1 2026, down 300.0% year-over-year from $2000.0 in Q1 2025, and little changed quarter-over-quarter from -$4000.0 in Q4 2025.
Silexion Therapeutics (SLXN) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Silexion Therapeutics' Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$4000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 300.0% year-over-year to -$4000.0; the TTM figure through Mar 2026 stood at -$8000.0 (up 86.67% YoY), while the FY2025 annual figure was -$5000.0, up 91.23% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$4000.0, roughly flat from -$4000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $47000.0 in Q1 2026, with the low at -$21000.0 in Q4 2024.
- The 3-year median for Other Working Capital Changes is $0.0 (2024), against an average of $3500.0.
- Peak annual rise in Other Working Capital Changes reached 200.0% in 2024, while the deepest fall reached 2100.0% in 2024.
- Silexion Therapeutics' Other Working Capital Changes stood at $13000.0 in 2023, then tumbled by 230.77% to -$17000.0 in 2024, then soared by 76.47% to -$4000.0 in 2025, then changed by 0.0% to -$4000.0 in 2026.
- Business Quant data shows SLXN's Other Working Capital Changes at -$4000.0 in Q1 2026, -$4000.0 in Q4 2025, and -$2000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - |
| 10 | Silexion Therapeutics | 263,256.19 | -1.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7,000.00 |
| Jun 30, 2026 | -7,000.00 |
| Jun 30, 2026 | -7,000.00 |
| Mar 31, 2026 | -4,000.00 |
| Mar 31, 2026 | -4,000.00 |
| Mar 31, 2026 | -4,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -17,000.00 |
| Dec 31, 2024 | -17,000.00 |